Krystal Biotech, Inc.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical…
Biotechnology
US, Pittsburgh [HQ]
Financials
Earnings Call Transcripts
Earnings Call · Transcripts · SpeakersThis analysis tool shows transcript versions of the official earnings calls hosted by Krystal Biotech, Inc.
Could not find a transcript
Peers Transcripts
Peers Analysis-
Sorry! None of KRYS's peers has listed transcripts.
Upcoming Transcript Tools
- Full Text Search - Across All Transcripts
- Detail Speaker Profiles
- Non-US Transcripts